Microtubule transport defects in neurological and ciliary disease

Cellular and Molecular Life Sciences

Volumn 62, Issue 14, 2005, Pages 1556-1570

  Gerdes, J M ^a   Katsanis, N ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Dynein; Intraflagellar transport; Kinesin; Microtubule associated proteins; Neurodegeneration

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARRIER PROTEIN; DYNEIN ADENOSINE TRIPHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3; KINESIN; MICROTUBULE ASSOCIATED PROTEIN; SONIC HEDGEHOG PROTEIN;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; BARDET BIEDL SYNDROME; CARBOXY TERMINAL SEQUENCE; CELL STRUCTURE; CILIARY MOTILITY; DNA MODIFICATION; DROSOPHILA; FLAGELLUM; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LETHALITY; MICROTUBULE; MOTOR NEURON DISEASE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PROTEIN DEFECT; REVIEW; TRANSPORT AT THE CELLULAR LEVEL; TRANSPORT KINETICS; TRANSPORT MEDIUM;

BIOLOGICAL TRANSPORT; CILIARY MOTILITY DISORDERS; DYNEIN ATPASE; HUMANS; KINESIN; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; MODELS, BIOLOGICAL; NERVOUS SYSTEM DISEASES;

EID: 22544476257     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-5007-5     Document Type: Review

References (152)

1. Keating T. J., Peloquin J. G., Rodionov V. I., Momcilovic D. and Borisy G. G. (1997) Microtubule release from the centrosome. Proc. Natl. Acad. Sci. USA 94: 5078-5083
2. Waterman-Storer C. M. and Salmon E. D. (1997) Actomyosin-based retrograde flow of microtubules in the lamella of migrating epithelial cells influences microtubule dynamic instability and turnover and is associated with microtubule breakage and treadmilling. J. Cell Biol. 139: 417-434
3. Rodionov V. I. and Borisy G. G. (1997) Microtubule treadmilling in vivo. Science 275: 215-218
4. Rodionov V., Nadezhdina E. and Borisy G. (1999) Centrosomal control of microtubule dynamics. Proc. Natl. Acad. Sci. USA 96: 115-120
5. Vorobjev I. A., Rodionov V. I., Maly I. V. and Borisy G. G. (1999) Contribution of plus and minus end pathways to microtubule turnover. J. Cell Sci. 112: 2277-2289
6. Yvon A. M. C. and Wadsworth P. (1997) Non-centrosomal microtubule formation and measurement of minus end microtubule dynamics in A498 cells. J. Cell Sci. 110: 2391-2401
7. Mollinedo F. and Gajate C. (2003) Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8: 413-450
8. Su Q. N., Cai Q., Gerwin C., Smith C. L. and Sheng Z. H. (2004) Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons. Nat. Cell Biol. 6: 941-953
9. Hirokawa N. (1998) Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279: 519-526
10. Vallee R. B., Williams J. C., Varma D. and Barnhart L. E. (2003) Dynein: an ancient motor protein involved in multiple modes of transport. J. Neurobiol. 58: 189-200
11. Mandelkow E. and Mandelkow E.-M. (2002) Kinesin motors and disease. Trends Cell Biol. 12: 585-591
12. Milisav I. (1998) Dynein and dynein-related genes. Cell Motil. Cytoskeleton 39: 261-272
13. Miki H., Setou M., Kaneshiro K. and Hirokawa N. (2001) All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. USA 98: 7004-7011
14. Gunawardena S. and Goldstein L. S. B. (2003) Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease. J. Neurobiol. 58: 258-271
15. Waterman-Storer C. M., Karki S. and Holzbaur E. L. F. (1995) The p150Glued component of the dynactin complex binds to both microtubules and the actin-related protein centractin (Arp1). Proc. Natl. Acad. Sci. USA 92: 1634-1638
16. Vaisberg E. A., Grissom P. M., Gill S. R., Schroer T. A. and McIntosh J. R. (1997) Cytoplasmic dynein 2 and dynactin are part of the ER to Golgi transport pathway. Mol. Biol. Cell 8: 2368-2368
17. Mikami A., Tynan S. H., Hama T., Luby-Phelps K., Saito T., Crandall J. E. et al. (2002) Molecular structure of cytoplasmic dynein 2 and its distribution in neuronal and ciliated cells. J. Cell Sci. 115: 4801-4808
18. Collins C. A. and Vallee R. B. (1989) Preparation of microtubules from rat liver and testis: cytoplasmic dynein is a major microtubule associated protein. Cell Motil. Cytoskeleton 14: 491-500
19. Gill S., Schroer T., Szilak I., Steuer E., Sheetz M. and Cleveland D. (1991) Dynactin, a conserved, ubiquitously expressed component of an activator of vesicle motility mediated by cytoplasmic dynein. J. Cell Biol. 115: 1639-1650
20. Paschal B. M., Holzbaur E. E. F., Pfister K. K., Clark S., Meyer D. I. and Vallee R. B. (1993) Characterization of a 50-kDa polypeptide in cytoplasmic dynein preparations reveals a complex with P150(Glued) and a novel actin. J. Biol. Chem. 268: 15318-15323
21. Schafer D., Gill S., Cooper J., Heuser J. and Schroer T. (1994) Ultrastructural analysis of the dynactin complex: an actin-related protein is a component of a filament that resembles F-actin. J. Cell Biol. 126: 403-412
22. King S. R. and Schroer T. A. (2000) Dynactin increases the processivity of the cytoplasmic dynein motor. Nat. Cell Biol. 2: 20-24
23. Vaughan K. T. and Vallee R. B. (1995) Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p150Glued. J. Cell Biol. 131: 1507-1516
24. Holleran E. A., Tokito M. K., Karki S. and Holzbaur E. L. F. (1996) Centractin (ARP1) associates with spectrin revealing a potential mechanism to link dynactin to intracellular organelles. J. Cell Biol. 135: 1815-1829
25. Holleran E. A., Ligon L. A., Tokito M. K., Stankewich M. C., Morrow J. S. and Holzbaur E. L. F. (2001) Beta-III spectrin binds to the ARP1 subunit of dynactin. J. Biol. Chem. 270: 36598-36605
26. Muresan V., Stankewich M. C., Steffen W., Morrow J. S. and Schnapp B. J. (2001) Dynactin-dependent, dynein-driven vesicle transport in the absence of membrane proteins: a role for spectrin and acidic phospholipids. Mol. Cell 7: 173-183
27. Echeverri C. J., Paschal B. M., Vaughan K. T. and Vallee R. B. (1996) Molecular characterization of the 50-kD subunit of dynactin reveals function for the complex in chromosome alignment and spindle organization during mitosis. J. Cell Biol. 132: 617-633
28. Deacon S. W., Serpinskaya A. S., Vaughan P. S., Fanarraga M. I., Vernos I., Vaughan K. T. et al. (2003) Dynactin is required for bidirectional organelle transport. J. Cell Biol. 160: 297-301
29. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S. et al. (2003) Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300: 808-812
30. Puls I., Jonnakuty C., LaMonte B. H., Holzbaur E. L. F., Tokito M., Mann E. et al. (2003) Mutant dynactin in motor neuron disease. Nat. Genet. 33: 455-456
31. LaMonte B. H., Wallace K. E., Holloway B. A., Shelly S. S., Ascano J., Tokito M. et al. (2002) Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34: 715-727
32. Vallee R. B. and Bloom G. S. (1991) Mechanisms of fast and slow axonal transport. Annu. Rev. of Neurosci. 14: 59-92
33. Wang L., Ho C., Sun D., Liem R. K. H. and Brown A. (2000) Rapid movements of axonal neurofilaments interrupted by prolonged pauses. Nat. Cell Biol. 2: 137-141
34. Ross C. A. (2002) Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 35: 819-822
35. Li X.-J., Li S. H., Sharp A. H., Nucifora F. C., Schilling G., Lanahan A. et al. (1995) A huntingtin-associated protein enriched in brain with implication for pathology. Nature 378: 398-402
36. Engelender S., Sharp A. H., Colomer V., Tokito M. K., Lanahan A., Worley P. et al. (1997) Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 6: 2205-2212
37. Vonsattel J. P., Myers R. H., Stevens T. J., Ferrante R. J. and Bird E. D. (1985) Neuropathological classification of Huntington's disease. J. Neuropath. Exp. Neurol. 44: 559-577
38. Gauthier L. R., Charrin B. C., Borrell-Pages M., Dompierre J. P., Rangone H., Cordelieres F. P. et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118: 127-138
39. Zeitlin S., Liu J. P., Chapman D. L., Papaioannou V. E. and Efstratiadis A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat. Genet. 11: 155-163
40. White J. K., Auerbach W., Duayo M. P., Vonsattel J. P., Gusella J. F., Joyner A. L. et al. (1997) Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat. Genet. 17: 404-410
41. Dragatsis I., Levine M. S. and Zeitlin S. (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat. Genet. 26: 300-306
42. Ferrer I., Goutan E., Marin C., Rey M. J. and Ribalta T. (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res. 866: 257-261
43. Li S. H., Gutekunst C. A., Hersch S. M. and Li X. J. (1998) Interaction of huntingtin-associated protein with dynactin p150Glued. J. Neurosci 19: 10428-10437
44. Gunawardena S., Her L. S., Brusch R. G., Laymon R. A., Niesman I. R., Gordesky-Gold B. et al. (2003) Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ-proteins in Drosophila. Neuron 40: 25-40
45. Szebenyi G., Morfini G. A., Babcock A., Gould M., Selkoe K., Stenoien D. L. et al. (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40: 41-52
46. Zuccato C., Ciammola A., Rigamonti D., Leavitt B. R., Goffredo D., Conti L. et al. (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293: 493-498
47. Baquet Z. C., Gorski J. A. and Jones K. R. (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J. Neurosci. 24: 4250-4258
48. Saudou F., Finkbeiner S., Devys D. and Greenberg M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis, but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55-66
49. Kanai Y., Okada Y., Tanaka Y., Harada A., Terada S. and Hirokawa N. (2000) KIF5C, a novel neuronal kinesin enriched in motor neurons. J. Neurosci. 20: 6374-6384
50. Trettel F., Rigamonti D., Hildtich-Maguire P., Wheeler V. C., Sharp A. H., Perischetti F. et al. (2000) Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells. Hum. Mol. Genet. 9: 2799-2809
51. Ohka S., Matsuda N., Tohyama K., Oda T., Morikawa M., Kuge S. et al. (2004) Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J. Virol. 78: 7186-7198
52. Douglas M. W., Diefenbach R. J., Homa F. L., Miranda-Saksena M., Rixon F. J., Vittone V. et al. (2004) Herpes simplex virus type 1 capsid protein VP26 interacts with dynein light chains RP3 and Tctex1 and plays a role in retrograde cellular transport. J. Biol. Chem. 279: 28522-28530
53. Diefenbach R. J., Miranda-Saksena M., Diefenbach E., Holland D. J., Boadle R. A., Armati P. J. et al. (2002) Herpes simplex virus tegument protein US11 interacts with conventional kinesin heavy chain. J. Virol. 76: 3282-3291
54. Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S. et al. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105: 587-597
55. Phinney A. L., Horne P., Yang J., Janus C., Bergeron C. and Westaway D. (2003) Mouse models of Alzheimer's disease: the long and filamentous road. Neurol. Res. 25: 590-600
56. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A., George-Hyslop P. S., Keuren M. L. V. et al. (1987) Amyloid beta protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235: 880-884
57. Heston L. L. (1977) Alzheimer's disease, trisomy 21 and myeloproliferative disorders: associations suggesting a genetic diathesis. Science 196: 322-323
58. Duff K., Eckman C., Zehr C., Yu X., Prada C. M., Pereztur J. et al. (1996) Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383: 710-713
59. Czech C., Tremp G. and Pradier E. (2000) Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms. Prog. Neurobiol. 60: 363-384
60. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K. et al. (1998) Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. USA 95: 9637-9641
61. Kang D. E., Soriano S., Frosch M. P., Collins T., Naruse S., Sisodia S. S. et al. (1999) Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway. J. Neurosci. 19: 4229-4237
62. Gantier R., Gilbert D., Dumanchin C., Campion D., Davoust D., Toma F. et al. (2000) The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3 beta. Neurosci. Lett. 283: 217-220
63. Cohen P. and Frame S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2: 769-776
64. Pigino G., Morfini G., Pelsman A., Mattson M. P., Brady S. T. and Busciglio J. (2003) Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23: 4499-4508
65. Morfini G., Szebenyi G., Brown H., Pant H. C., Pigino G., Boer S. D. et al. (2004) A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23: 2235-2245
66. Kamal A., Alenar-Queralt A., LeBlanc J. F., Roberts E. A. and Goldstein L. S. B. (2001) Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414: 643-648
67. Kamal A., Stokin G. D., Yang Z., Xia C.-H. and Goldstein L. S. B. (2000) Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-1. Neuron 28: 449-459
68. Matsuda S., Matsuda Y. and D'Adamio L. (2003) Amyloid beta protein precursor (AbetaPP), but not AbetaPP-like protein 2, is bridged to the kinesin light chain by the scaffold protein JNK-interacting protein 1. J. Biol. Chem. 278: 38601-38606
69. Gunawardena S. and Goldstein L. S. B. (2001) Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron 32: 389-401
70. Hirashima N., Nishio M. and Nakanishi M. (2000) Intracellular dynamics of a high affinity NGF receptor TrkA in PC12 cell. Biol. Pharm. Bull. 23: 1097-1099
71. Baker M., Graff-Radford D., DeVrieze F. W., Graff-Radford N., Petersen R. C., Kokmen E. et al. (2000) No association between TAU haplotype and Alzheimer's disease in population or clinic based series or in familial disease. Neurosci. Lett. 285: 147-149
72. Bullido M. J., Aldudo J., Frank A., Coria F., Avila J. and Valdivieso F. (2000) A polymorphism in the tau gene associated with risk for Alzheimer's disease. Neurosci. Lett. 278: 49-52
73. Geschwind, D.H. (2003) Tau phosphorylation, tangles and neurodegeneration: the chicken or the egg? Neuron 40: 457-460
74. Higuchi M., Lee V. M. Y. and Trojanowski J. Q. (2002) Tau and axonopathy in neurodegenerative disorders. Neuromol. Med. 2: 131-150
75. Rademakers R., Cruts M. and van Broeckhoven C. (2004) The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum. Mutat. 24: 277-295
76. Schraen-Maschke S., Dhaenens C.-M., Delacourte A. and Sablonniere B. (2004) Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases. Neurobiol. Dis. 15: 449-460
77. Hinchcliffe E. H., Miller F. J., Cham M., Khodjakov A. and Sluder G. (2001) Requirement of a centrosomal activity for cell cycle progression through G1 into S phase. Science 291: 1547-1550
78. Khodjakov A. and Rieder C. L. (2001) Centrosomes enhance the fidelity of cytokinesis in vertebrates and are required for cell cycle progression. J. Cell Biol. 153: 237-242
79. Pazour G. J. and Witman G. B. (2003) The vertebrate primary cilium is a sensory organelle. Curr. Opin. Cell Biol. 15: 105-110
80. Cole D. G., Diener D. R., Himelblau A. L., Beech P. L., Fuster J. C. and Rosenbaum J. L. (1998) Chlamydomonas kinesin-II-dependent intraflagellar transport (IFT): IFT particles contain proteins required for ciliary assembly in Caenorhabditis elegans sensory neurons. J. Cell Biol. 141: 993-1008
81. Deane J. A., Cole D. G., Seeley E. S., Diener D. R. and Rosenbaum J. L. (2001) Localization of intraflagellar transport protein IFT52 identifies basal body transitional fibers as the docking site for IFT particles. Curr. Biol. 11: 1586-1590
82. Piperno G. and Mead K. (1997) Transport of a novel complex in the cytoplasmic matrix of Chlamydomonas flagella. Proc. Natl. Acad. Sci. USA 94: 4457-4462
83. Yokoyama T., Copeland N. G., Jenkins N. A., Montgomery C. A., Elder F. F. B. and Overbeek P. A. (1993) Reversal of left-right asymmetry: a situs-inversus mutation. Science 260: 679-682
84. Okada Y., Nonaka S., Tanaka Y., Saijoh Y., Hamada H. and Hirokawa N. (1999) Abnormal nodal flow precedes situs inversus in iv and inv mice. Mol. Cell 4: 459-468
85. Nauli S. M., Alenghat F. J., Luo Y., Williams E., Vassilev P., Lil X. G. et al. (2003) Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33: 129-137
86. Satir P. (1999) The cilium as a biological nanomachine. FASEB J. 13: S235-S237
87. McGrath J. and Brueckner M. (2003) Cilia are at the heart of vertebrate left-right asymmetry. Curr. Opin. Gen. Dev. 13: 385-392
88. Rosenbaum J. L. and Witman G. B. (2002) Intraflagellar transport. Nat. Rev. Mol. Cell Biol. 3: 813-825
89. Pazour G. J. and Rosenbaum J. L. (2002) Intraflagellar transport and cilia-dependent diseases. Trends Cell Biol. 12: 551-555
90. Sloboda R. D. (2002) A healthy understanding of intraflagellar transport. Cell Motil. Cytoskeleton 52: 1-8
91. Snow J. J., Ou G., Gunnarson A. L., Walker M. R. S., Zhou H. M., Brust-Mascher I. et al. (2004) Two anterograde intraflagellar transport motors cooperate to build sensory cilia on C. elegans neurons. Nat. Cell Biol. 6: 1109-1113
92. Marszalek J. R., Ruiz-Lozano P., Roberts E., Chien K. R. and Goldstein L. S. B. (1999) Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. Proc. Natl. Acad. Sci. USA 96: 5043-5048
93. Snell W. J., Pan J. and Wang Q. (2004) Cilia and flagella revealed: from flagellar assembly in Chlamydomonas to human obesity disorders. Cell 117: 693-697
94. Berman S. A., Wilson N. F., Haas N. A. and Lefebvre P. A. (2003) A novel MAP kinase regulates flagellar length in Chlamydomonas. Curr. Biol. 12: 1145-1149
95. Pedersen L. B., Geimer S., Sloboda R. D. and Rosenbaum J. L. (2003) The microtubule plus end-tracking protein EB1 is localized to the flagellar tip and basal bodies in Chlamydomonas reinhardtii. Curr. Biol. 13: 1969-1974
96. Wilson P. D. (2004) Polycystic kidney disease. N Engl J Med 350: 151-164
97. Ward C. J., Peral B., Hughes J., Thomas S., Gamble V., Maccarthy A. B. et al. (1994) The polycystic kidney disease 1 gene encodes a 14 Kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 881-894
98. Mochizuki T., Wu G. Q., Hayashi T., Xenophontos S. L., Veldhuisen B., Saris J. J. et al. (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342
99. Ward C. J., Hogan M. C., Rossetti S., Walker D., Sneddon T., Wang X. F. et al. (2002) The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 30: 259-269
100. Wang S. X., Luo Y., Wilson P. D., Witman G. B. and Zhou J. (2004) The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area. J. Am. Soc. Nephrol. 15: 592-602
101. Praetorius H. A. and Spring K. R. (2003) Removal of the MDCK cell primary cilium abolishes flow sensing. J. Membr. Biol. 191: 69-76
102. Praetorius H. A. and Spring K. R. (2001) Bending the MDCK cell primary cilium increases intracellular calcium. J. Membr. Biol. 184: 71-79
103. Pazour G. J., Dickert B. L., Vucica Y., Seeley E. S., Rosenbaum J. L., Witman G. B. et al. (2000) Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene Tg737, are required for assembly of cilia and flagella. J. Cell Biol. 151: 709-718
104. Hou X. Y. Mrug M., Yoder B. K., Lefkowitz E. J., Kremmidiotis G., D'Eustachio P. et al. (2002) Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease. J. Clin. Invest. 109: 533-540
105. Murcia N. S., Richards W. G., Yoder B. K., Mucenski M. L., Dunlap J. R. and Woychik R. P. (2000) The Oak Ridge Polycystic Kidney (orpk) disease gene is required for left-right axis determination. Development 127: 2347-2355
106. Marszalek J. R., Liu X. R., Roberts E. A., Chui D., Marth J. D., Williams D. S. et al. (2000) Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors. Cell 102: 175-187
107. Katsanis N. (2004) The oligogenic properties of Bardet-Biedl syndrome. Hum. Mol. Genet. 13: R65-R71
108. Badano J. L., Ansley S. J., Leitch C. C., Lewis R. A., Lupski J. R. and Katsanis N. (2003) Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am. J. Hum. Genet. 72: 650-658
109. Mykytyn K., Braun T., Carmi R., Haider N. B., Searby C. C., Shastri M. et al. (2001) Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat. Genet. 28: 188-191
110. Mykytyn K., Nishimura D. Y., Searby C. C., Shastri M., Yen H. J., Beck J. S. et al. (2002) Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat. Genet. 31: 435-438
111. Nishimura D. Y., Searby C. C., Carmi R., Elbedour K., Van Maldergem L., Fulton A. B. et al. (2001) Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum. Mol. Gen. 10: 865-874
112. Ansley S. J., Badano J. L., Blacque O. E., Hill J., Hoskins B. E., Leitch C. C. et al. (2003) Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425: 628-633
113. Fan Y. L., Esmail M. A., Ansley S. J., Blacque O. E., Boroevich K., Ross A. J. et al. (2004) Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat. Genet. 36: 989-993
114. Katsanis N., Beales P. L., Woods M. O., Lewis R. A., Green J. S., Parfrey P. S. et al. (2000) Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat. Genet. 26: 67-70
115. Slavotinek A. M., Stone E. M., Mykytyn K., Heckenlively J. R., Green J. S., Heon E. et al. (2000) Mutations in MKKS cause Bardet-Biedl Syndrome. Nat. Genet. 26: 15-16
116. Li J. B., Gerdes J. M., Haycraft C. J., Fan Y. L., Teslovich T. M., May-Simera H. et al. (2004) Comparative and basal genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 117: 541-552
117. Badano J. L. and Katsanis N. (2002) Beyond Mendel: an evolving view of human genetic disease transmission. Nat. Rev. Genet. 3: 779-789
118. Badano J. L., Kim J. C., Hoskins B. E., Lewis R. A., Ansley S. J., Cutler D. J. et al. (2003) Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Am. J. Hum. Genet. 73: 518-518
119. Beales P. L., Badano J. L., Ross A. J., Ansley S. J., Hoskins B. E., Kirsten B. et al. (2003) Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome. Am. J. Hum. Genet. 72: 1187-1199
120. Katsanis N., Ansley S. J., Badano J. L., Eichers E. R., Lewis R. A., Hoskins B. et al. (2001) Triallelic inheritance in Bardet-Biedl syndrome, a recessive, genetically heterogeneous, and pleiotropic disorder. Am. J. Hum. Genet. 69: 226-226
121. Katsanis N., Eichers E. R., Ansley S. J., Lewis R. A., Kayserili H., Hoskins B. E. et al. (2002) BBS4 is a minor contributor to Bardet-Biedl syndrome and may also participate in triallelic inheritance. Am. J. Hum. Genet. 71: 22-29
122. Nonaka S., Tanaka Y., Okada Y., Takeda S., Harada A., Kanai Y. et al. (1998) Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell 95: 829-837
123. Blacque O. E., ReardonM. J., Li C. M., McCarthy J., Mahjoub M. R., Ansley S. J. et al. (2004) Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev. 18: 1630-1642
124. Kim J. C., Badano J. L., Sibold S., Esmail M. A., Hill J., Hoskins B. E. et al. (2004) The Bardet-Biedl protein BBS4 targets cargo to the pericentriolar region and is required for microtubule anchoring and cell cycle progression. Nat. Genet. 36: 462-470
125. Balczon R., Bao L. M. and Zimmer W. E. (1994) Pcm-1, a 228-kD centrosome autoantigen with a distinct cell cycle distribution. J. Cell Biol. 124: 783-793
126. Kulaga H. M., Leitch C. C., Eichers E. R., Badano J. L., Lesemann A., Hoskins B. E. et al. (2004) Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse. Nat. Genet. 36: 994-998
127. Brenman J. E., Topinka J. R., Cooper E. C., McGee A. W., Rosen J., Milroy T. et al. (1998) Localization of postsynaptic density-93 to dendritic microtubules and interaction with microtubule-associated protein 1A. J. Neurosci. 18: 8805-8813
128. Thomas U., Ebitsch S., Gorczyca M., Koh Y. H., Hough C. D., Woods D. et al. (2000) Synaptic targeting and localization of Discs-large is a stepwise process controlled by different domains of the protein. Curr. Biol. 10: 1108-1117
129. Ikeda A., Zheng Q. Y., Zuberi A. R., Johnson K. R., Naggert J. K. and Nishina P. M. (2002) Microtubule-associated protein 1a is a modifier of tubby hearing (moth1). Nat. Genet. 30: 401-405
130. Ikeda A., Zheng Q. Y., Rosenstiel P., Maddatu T., Zuberi A. R., Roopenian D. C. et al. (1999) Genetic modification of hearing in tubby mice: evidence for the existence of a major gene (moth1) which protects tubby mice from hearing loss. Hum. Mol. Gen. 8: 1761-1767
131. Migaud M., Charlesworth P., Dempster M., Webster L. C., Watabe A. M., Makhinson M. et al. (1998) Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396: 433-439
132. Carroll K., Gomez C. and Shapiro L. (2004) Tubby proteins: the plot thickens. Nat. Rev. Mol. Cell Biol. 5: 55-63
133. Huangfu D., Liu A., Rakeman A. S., Murcia N. S., Niswander L. and Anderson K. V. (2003) Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 426: 83-87
134. Amack J. D. and Yost H. J. (2004) The T box transcription factor no tail in ciliated cells controls zebrafish left-right asymmetry. Curr. Biol. 14: 685-690
135. Fan S., Hurd T. W., Liu C.-J., Straight S. W., Weimbs T., Hurd E. A. et al. (2004) Polarity proteins control ciliogenesis via kinesin motor interactions. Curr. Biol. 14: 1451-1451
136. Bartoloni L., Blouin J.-L., Pan Y., Gehrig C., Maiti A. K., Scamuffa N. et al. (2002) Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc. Nat. Acad. Sci. USA 99: 10282-10286
137. Olbrich H., Haffner K., Kispert A., Volkel A., Volz A., Sasmaz G. et al. (2002) Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat. Genet. 30: 143-144
138. Guichard C., Harricane M.-C., Lafitte J.-J., Godard P., Zaegel M., Tack V. et al. (2001) Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome). Am. J. Hum. Genet. 68: 1030-1035
139. Chong S. S., Lo Nigro C., Roschke A. V., Tanigami A., Pack S. D., Smith A. C. M. et al. (1996) Point mutations and an intragenic deletion in three ILS patients confirm LIS1 as the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Am. J. Hum. Genet. 59: Suppl.: A23 only
140. Wattendorff A., Bots G., Went L., Endtz L. (1982) Familial cerebral amyloid angiopathy presenting as recurrent cerebral haemorrhage. J. Neurol. Sci. 55: 121-135
141. Goate A., Chartier-Harlin M.-C., Mullan M., Brown J., Crawford F., Fidani L. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706
142. Hendriks L., Duijn C. M. V., Cras P., Cruts M., Hul W. V., Harskamp F. V. et al. (1992) Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat. Genet. 1: 218-221
143. Sherrington R., Rogaev E., Liang Y., Rogaeva E. A., Levesque G., Ikeda M. et al. (1995) Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760
144. Raux G., Gantier R., Thomas-Anterion C., Boulliat J., Verpillat P., Hannequin D. et al. (2000) Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation. Neurology 55: 1577-1578
145. Dermaut B., Kumar-Singh S., Engelborghs S., Theuns J., Rademakers R., Saerens J. et al. (2004) A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann. Neurol. 55: 617-626
146. Yamada K., Andrews C., Chan W.-M., McKeown C. A., Magli A., Barardinis T. D. et al. (2003) Heterozygous mutations of the kinesin KIF21A in congenital fibrosis of the extraocular muscles type 1 (CFEOM1). Nat. Genet. 35: 318-321
147. Reed L. A., Grabowski T. J., Schmidt M. L., Morris J. C., Goate A., Solodkin A. et al. (1997) Autosomal dominant dementia with widespread neurofibrillary tangles. Ann. Neurol. 42: 564-572
148. Heutink P., Stevens M., Rizzu P., Bakker E., Kros J. M., Tibben A. et al. (1997) Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families. Ann. Neurol. 41: 150-159
149. Hutton M., Lendon C. L., Rizzu P., Baker M., Froelich S., Houlden H. et al. (1998) Association of missense and 5-prime-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705
150. Murrell J. R., Spillantini M. G., Zolo P., Guazzelli M., Smith M. J., Hasegawa M. et al. (1999) Tau gene mutation G389R causes a tauopathy with abundant Pick body-like inclusions and axonal deposits. J. Neuropath. Exp. Neurol. 58: 1207-1226
151. Clark L. N., Poorkaj P., Wszolek Z., Geschwind D. H., Nasreddine Z. S., Miller B. et al. (1998) Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc. Nat. Acad. Sci. USA 95: 13103-13107
152. Poorkaj P., Muma N. A., Zhukareva V., Cochran E. J., Shannon K. M., Hurtig H. et al. (2002) An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol. 52: 511-516